| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Apex Biotechnology Corp (TW: 1733)
1733 Technical Analysis
1.5
| As on 25th Nov 2025 1733 STOCK Price closed @ 30.35 and we RECOMMEND Sell for LONG-TERM with Stoploss of 30.83 & Buy for SHORT-TERM with Stoploss of 29.83 we also expect STOCK to react on Following IMPORTANT LEVELS. |
1733STOCK Price
| Open | 30.40 | Change | Price | % |
| High | 30.65 | 1 Day | 0.10 | 0.33 |
| Low | 30.30 | 1 Week | -0.40 | -1.30 |
| Close | 30.35 | 1 Month | -5.20 | -14.63 |
| Volume | 63206 | 1 Year | 2.30 | 8.20 |
| 52 Week High 37.50 | 52 Week Low 26.50 | ||||
TW Taiwan Most Active Stocks
| 2888 | 11.80 | 3.96% |
| 2344 | 57.50 | 5.31% |
| 2408 | 143.50 | 0.35% |
| 1303 | 52.40 | -4.38% |
| 1802 | 32.45 | -1.67% |
| 2337 | 34.50 | 1.92% |
| 2881 | 92.90 | 0.98% |
| 2317 | 219.00 | -0.45% |
| 2409 | 11.05 | 1.84% |
| 8021 | 139.50 | 9.84% |
TW Taiwan Top Gainers Stocks
TW Taiwan Top Losers Stocks
| 1733 Daily Charts |
1733 Intraday Charts |
Whats New @ Bazaartrend |
1733 Free Analysis |
|
|
1733 Important Levels Intraday
| RESISTANCE | 31.02 |
| RESISTANCE | 30.81 |
| RESISTANCE | 30.67 |
| RESISTANCE | 30.54 |
| SUPPORT | 30.16 |
| SUPPORT | 30.03 |
| SUPPORT | 29.89 |
| SUPPORT | 29.68 |
1733 Forecast November 2025
| 4th UP Forecast | 36.23 |
| 3rd UP Forecast | 34.34 |
| 2nd UP Forecast | 33.18 |
| 1st UP Forecast | 32.01 |
| 1st DOWN Forecast | 28.69 |
| 2nd DOWN Forecast | 27.52 |
| 3rd DOWN Forecast | 26.36 |
| 4th DOWN Forecast | 24.47 |
1733 Weekly Forecast
| 4th UP Forecast | 33.34 |
| 3rd UP Forecast | 32.38 |
| 2nd UP Forecast | 31.79 |
| 1st UP Forecast | 31.19 |
| 1st DOWN Forecast | 29.51 |
| 2nd DOWN Forecast | 28.91 |
| 3rd DOWN Forecast | 28.32 |
| 4th DOWN Forecast | 27.36 |
1733 Forecast2025
| 4th UP Forecast | 54.05 |
| 3rd UP Forecast | 46.45 |
| 2nd UP Forecast | 41.75 |
| 1st UP Forecast | 37.05 |
| 1st DOWN Forecast | 23.65 |
| 2nd DOWN Forecast | 18.95 |
| 3rd DOWN Forecast | 14.25 |
| 4th DOWN Forecast | 6.65 |
Apex Biotechnology Corp ( TW Taiwan Symbol : 1733 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
1733 Other Details
| Segment | EQ | |
| Market Capital | 2305546496.00 | |
| Sector | Healthcare | |
| Industry | Biotechnology | |
| Offical website | > echo $website ; ?> | |
1733 Address
![]() |
||
1733 Latest News
1733 Business Profile
Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residues check systems; and care management and tele-health services. The company was founded in 1997 and is headquartered in Hsinchu City, Taiwan. Address: No. 7, Li-Hsin 5th Road, Hsinchu City, Taiwan, 30078
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

